Brock Reeve | CEO
Eos Bioinnovation

Brock Reeve is the CEO and Co-Founder of Eos BioInnovation, an early-stage investment company focused on the regenerative medicine field. Eos is dedicated to incubating and seeding companies across modalities and indications based on research from leading academic labs. Prior to forming Eos in 2022, Brock was the Executive Director of the Harvard Stem Cell Institute since 2006 where he had overall responsibility for the operations and strategy of the Institute. HSCI invested in scientific research and development across a faculty of over 370 Principal and Affiliated members. Brock was the initial CEO of IVIVA Medical, an HSCI faculty startup, and represents Eos on the boards of its portfolio companies.